TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/24 07:38 | 6/15/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Satchi-Fainaro Ronit | L3 | D | M.d | 0 | 0.00 | 0 | 21 | 31 | 88 | D | |||||||||||||||
8/7/23 16:09 | 8/4/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Satchi-Fainaro Ronit | L3 | D | M.d | 0 | 0.00 | 0 | 16 | 31 | 67 | D | |||||||||||||||
6/16/22 07:42 | 6/14/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Satchi-Fainaro Ronit | L3 | D | M.d | 0 | 0.00 | 0 | 14 | 39 | 51 | D | |||||||||||||||
6/10/21 07:46 | 6/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Satchi-Fainaro Ronit | L3 | D | M.d | 0 | 0.00 | 0 | 13 | 54 | 36 | D | |||||||||||||||
6/8/21 07:32 | 6/5/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Satchi-Fainaro Ronit | L3 | D | M.d | 0 | 0.00 | 0 | 6 | 34 | 24 | D | |||||||||||||||
6/15/20 07:37 | 6/11/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Satchi-Fainaro Ronit | L3 | D | M.d | 0 | 0.00 | 0 | 18 | New | 18 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |